cagrilintide semaglutide combination cagrisema phase 3 results 2024 2025 Novo Nordisk's 2.4 mg / 2.4 mg demonstrated significant reduction in HbA1c and weight across multiple studies in the REIMAGINE program presented at ADA 2026 Another obesity contender just raised

GLP-1 receptor agonists are temperature-sensitive injectable peptide medicines that degrade if frozen or exposed to temperatures above 30C

Our team has seen patients spend six months trying to satisfy step therapy requirements before being denied anyway

Prolactin can mess with other important hormonal functions

Store the unopened vial in a clean, dry place away from direct sunlight and temperature extremes

3x Patchie (90 Patches): $26.99/pack, Save 50% + 25% OFF

The study included 338 participants with a body mass index (BMI) of 30 kg/m or higher, or 27 kg/m or higher with at least one weight-related comorbidity, all of whom received lifestyle interventions alongside the treatments [22]